These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7873386)

  • 1. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
    Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
    Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
    Beck J; Niethammer D; Gekeler V
    Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
    Beck J; Niethammer D; Gekeler V
    Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
    Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V
    Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
    Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
    Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
    Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
    Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.
    Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB
    Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of multidrug resistance associated genes in neuroblastomas.
    Bader P; Schilling F; Schlaud M; Girgert R; Handgretinger R; Klingebiel T; Treuner J; Liu C; Niethammer D; Beck JF
    Oncol Rep; 1999; 6(5):1143-6. PubMed ID: 10425316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.
    Schneider E; Cowan KH; Bader H; Toomey S; Schwartz GN; Karp JE; Burke PJ; Kaufmann SH
    Blood; 1995 Jan; 85(1):186-93. PubMed ID: 7528566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between cyclin A gene expression in adult patients with acute leukemia and drug resistance.
    Ma J; Xu S; Lai Y; Lu Y; Yao E
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):245-8. PubMed ID: 14526424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues.
    Schwarzenbach H
    Anal Biochem; 2002 Sep; 308(1):26-33. PubMed ID: 12234460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
    Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
    J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
    Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
    Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.